This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Xwpharma Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hao-wei Shih: Innovator in Pharmaceutical Chemistry
Introduction
Hao-wei Shih is a notable inventor based in Taipei, Taiwan. He is currently associated with Xwpharma Ltd., where he contributes to advancements in pharmaceutical chemistry. Despite having no granted patents to his name, his work in the field is significant and impactful.
Latest Patent Applications
Hao-wei Shih has submitted several patent applications that showcase his innovative approach to pharmaceutical compounds. One of his latest applications is for "Ketamine Derivatives and Compositions Thereof." This application discloses ketamine derivatives and pharmaceutical compositions that, when administered orally, provide increased bioavailability of ketamine in systemic circulation. These derivatives have potential applications in treating neurological diseases, psychological disorders, and pain management. Another application is titled "Methods of Synthesizing 4-Valyloxybutyric Acid." This disclosure outlines synthetic methods for preparing 4-valyloxybutyric acid, employing various protecting group strategies and reaction conditions. It also discusses compounds that serve as useful synthetic intermediates in the preparation of this acid.
Conclusion
Hao-wei Shih is an emerging inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patent applications reflect his commitment to advancing medical science and improving treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile